ACA exchange, Medicaid expansion coverage reaches record To view this email as a web page,
click here Could a breast cancer candidate treat COVID-19? Polyphor's drug shows dual action in early studies UPDATED Coronavirus tracker: Adolescent hospitalizations for COVID tick up in March, April, CDC says HHS: ACA exchange, Medicaid expansion coverage reaches record 31M Fueled by COVID drug manufacturing revenues, CDMO Jubilant HollisterStier invests in upgrades, expansion COVID-19 tracker: Obesity is the top risk factor for severe COVID, study says; Translate to get $50M milestone payment from Sanofi Merck investigating noose at NC vaccine plant as execs pledge swift response Featured Story | By Angus Liu A Swiss biotech suggests that one of its clinical candidates, currently in late-stage development for breast cancer, may also work as a COVID-19 treatment. The drug, called balixafortide, reduced viral load of the coronavirus that causes COVID, as well as COVID-related inflammation markers, in hamsters. read more |
| |
|---|
|
| | Benefits of Decentralized Clinical Trials To execute decentralized research strategies, sponsors are turning to an integrated supply chain solution known as Direct-to-Patient Services. This service allows patients to participate in clinical trials from their homes by providing them with study drugs and care where they live. Learn more. |
Top Stories By Healthcare Staff Follow along with the latest COVID-19 news straight from the Fierce Healthcare team. read more By Robert King A record 31 million people have received coverage through the ACA's insurance exchanges and Medicaid expansion, according to a new report from HHS. read more By Kevin Dunleavy Jubilant HollisterStier has been busy churning out COVID-19 treatments and is now turning those revenues from the increased business into an investment in the future. This week the Washington-based CDMO revealed a $92 million expansion plan. read more By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner A study shows that obesity is the highest risk factor predicting severe COVID-19 in those under 40. Translate Bio will receive $50M in milestone payments from Sanofi for mRNA vaccine development. And more headlines. read more By Kevin Dunleavy A noose was found hanging over a beam at a construction site at a Merck manufacturing facility in Durham, N.C. The New Jersey-based company sent an email to employees on Saturday, informing them of the discovery. Merck is investigating the incident. read more | | Webinar: Accelerating NASH Clinical Trials Tuesday, June 15 | 10am ET / 7am PT Join industry leaders for a webinar dedicated to overcoming key challenges presented in NASH drug development. We’ll explore key considerations for liver biopsy collection and interpretation, emerging non-invasive biomarkers, and the connection between clinical practice and drug development. Register now. |
|
|
